These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9469414)

  • 1. TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells.
    Takeuchi M; Alard P; Streilein JW
    J Immunol; 1998 Feb; 160(4):1589-97. PubMed ID: 9469414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T cell activation.
    Takeuchi M; Kosiewicz MM; Alard P; Streilein JW
    Eur J Immunol; 1997 Jul; 27(7):1648-56. PubMed ID: 9247573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of in vivo regulatory properties of T cells activated in vitro by TGFbeta2-treated antigen presenting cells.
    Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1410-21. PubMed ID: 10798657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation.
    Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1803-11. PubMed ID: 10845601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
    Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
    J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-presenting cells are targets of regulatory T cells similar to those that mediate anterior chamber-associated immune deviation.
    Yokoi H; Streilein JW
    Ocul Immunol Inflamm; 2004 Jun; 12(2):101-14. PubMed ID: 15512980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production.
    Peng X; Kasran A; Warmerdam PA; de Boer M; Ceuppens JL
    Eur J Immunol; 1996 Jul; 26(7):1621-7. PubMed ID: 8766570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel role for TGF-beta and IL-10 in the induction of immune privilege.
    D'Orazio TJ; Niederkorn JY
    J Immunol; 1998 Mar; 160(5):2089-98. PubMed ID: 9498745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40-CD154 interaction and IFN-gamma are required for IL-12 but not prostaglandin E2 secretion by microglia during antigen presentation to Th1 cells.
    Aloisi F; Penna G; Polazzi E; Minghetti L; Adorini L
    J Immunol; 1999 Feb; 162(3):1384-91. PubMed ID: 9973393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell immunity induced by allogeneic microglia in relation to neuronal retina transplantation.
    Ma N; Streilein JW
    J Immunol; 1999 Apr; 162(8):4482-9. PubMed ID: 10201985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possibility of inducing anterior chamber-associated immune deviation by TGF-beta2 treatment of monocytes isolated from Behcet's patients.
    Takeuchi M; Keino H; Suzuki J; Usui Y; Hattori T; Takeuchi A; Oh-I K; Okunuki Y; Kezuka T; Usui M
    Exp Eye Res; 2006 Oct; 83(4):981-8. PubMed ID: 16822510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
    Kosiewicz MM; Alard P; Liang S; Clark SL
    Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethanol consumption modifies dendritic cell antigen presentation in mice.
    Heinz R; Waltenbaugh C
    Alcohol Clin Exp Res; 2007 Oct; 31(10):1759-71. PubMed ID: 17850646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of transforming growth factor-beta production by interleukin-12.
    Marth T; Strober W; Seder RA; Kelsall BL
    Eur J Immunol; 1997 May; 27(5):1213-20. PubMed ID: 9174613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4.
    Macaulay AE; DeKruyff RH; Goodnow CC; Umetsu DT
    J Immunol; 1997 May; 158(9):4171-9. PubMed ID: 9126977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-beta-producing regulatory T cells.
    Yoshida M; Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3862-70. PubMed ID: 11053287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anterior chamber-associated immune deviation-inducing cells activate T cells, and rescue them from antigen-induced apoptosis.
    Takeuchi M; Alard P; Verbik D; Ksander B; Streilein JW
    Immunology; 1999 Dec; 98(4):576-83. PubMed ID: 10594691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production.
    Yoshimoto T; Takeda K; Tanaka T; Ohkusu K; Kashiwamura S; Okamura H; Akira S; Nakanishi K
    J Immunol; 1998 Oct; 161(7):3400-7. PubMed ID: 9759857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 in combination with TGF-beta favors an alternative pathway of Th1 development independent of IL-12.
    Lingnau K; Hoehn P; Kerdine S; Koelsch S; Neudoerfl C; Palm N; Ruede E; Schmitt E
    J Immunol; 1998 Nov; 161(9):4709-18. PubMed ID: 9794401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
    Schweitzer AN; Sharpe AH
    J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.